Literature DB >> 22245738

Innate response activator B cells protect against microbial sepsis.

Philipp J Rauch1, Aleksey Chudnovskiy, Clinton S Robbins, Georg F Weber, Martin Etzrodt, Ingo Hilgendorf, Elizabeth Tiglao, Jose-Luiz Figueiredo, Yoshiko Iwamoto, Igor Theurl, Rostic Gorbatov, Michael T Waring, Adam T Chicoine, Majd Mouded, Mikael J Pittet, Matthias Nahrendorf, Ralph Weissleder, Filip K Swirski.   

Abstract

Recognition and clearance of a bacterial infection are a fundamental properties of innate immunity. Here, we describe an effector B cell population that protects against microbial sepsis. Innate response activator (IRA) B cells are phenotypically and functionally distinct, develop and diverge from B1a B cells, depend on pattern-recognition receptors, and produce granulocyte-macrophage colony-stimulating factor. Specific deletion of IRA B cell activity impairs bacterial clearance, elicits a cytokine storm, and precipitates septic shock. These observations enrich our understanding of innate immunity, position IRA B cells as gatekeepers of bacterial infection, and identify new treatment avenues for infectious diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22245738      PMCID: PMC3279743          DOI: 10.1126/science.1215173

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  34 in total

Review 1.  Marginal-zone B cells.

Authors:  Flavius Martin; John F Kearney
Journal:  Nat Rev Immunol       Date:  2002-05       Impact factor: 53.106

2.  Integrin-mediated long-term B cell retention in the splenic marginal zone.

Authors:  Theresa T Lu; Jason G Cyster
Journal:  Science       Date:  2002-07-19       Impact factor: 47.728

3.  Resolution of three nonproliferative immature splenic B cell subsets reveals multiple selection points during peripheral B cell maturation.

Authors:  D Allman; R C Lindsley; W DeMuth; K Rudd; S A Shinton; R R Hardy
Journal:  J Immunol       Date:  2001-12-15       Impact factor: 5.422

4.  The epidemiology of sepsis in the United States from 1979 through 2000.

Authors:  Greg S Martin; David M Mannino; Stephanie Eaton; Marc Moss
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

5.  An essential role for BAFF in the normal development of B cells through a BCMA-independent pathway.

Authors:  B Schiemann; J L Gommerman; K Vora; T G Cachero; S Shulga-Morskaya; M Dobles; E Frew; M L Scott
Journal:  Science       Date:  2001-08-16       Impact factor: 47.728

6.  Granulocyte-macrophage colony-stimulating factor as an autocrine survival factor for mature normal and malignant B lymphocytes.

Authors:  R J Harris; A R Pettitt; C Schmutz; P D Sherrington; M Zuzel; J C Cawley; S D Griffiths
Journal:  J Immunol       Date:  2000-04-01       Impact factor: 5.422

Review 7.  The immunopathogenesis of sepsis.

Authors:  Jonathan Cohen
Journal:  Nature       Date:  2002 Dec 19-26       Impact factor: 49.962

8.  A small CD11b(+) human B1 cell subpopulation stimulates T cells and is expanded in lupus.

Authors:  Daniel O Griffin; Thomas L Rothstein
Journal:  J Exp Med       Date:  2011-11-21       Impact factor: 14.307

9.  Homeostasis of peripheral B cells in the absence of B cell influx from the bone marrow.

Authors:  Z Hao; K Rajewsky
Journal:  J Exp Med       Date:  2001-10-15       Impact factor: 14.307

10.  A new non-linear normalization method for reducing variability in DNA microarray experiments.

Authors:  Christopher Workman; Lars Juhl Jensen; Hanne Jarmer; Randy Berka; Laurent Gautier; Henrik Bjørn Nielser; Hans-Henrik Saxild; Claus Nielsen; Søren Brunak; Steen Knudsen
Journal:  Genome Biol       Date:  2002-08-30       Impact factor: 13.583

View more
  177 in total

Review 1.  A historical perspective on sepsis.

Authors:  Peter A Ward; Markus Bosmann
Journal:  Am J Pathol       Date:  2012-05-26       Impact factor: 4.307

Review 2.  The role of B-1 cells in inflammation.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

Review 3.  Lifestyle effects on hematopoiesis and atherosclerosis.

Authors:  Matthias Nahrendorf; Filip K Swirski
Journal:  Circ Res       Date:  2015-02-27       Impact factor: 17.367

4.  B-1a Cells Protect Mice from Sepsis: Critical Role of CREB.

Authors:  Monowar Aziz; Nichol E Holodick; Thomas L Rothstein; Ping Wang
Journal:  J Immunol       Date:  2017-06-19       Impact factor: 5.422

5.  IL-37- and IL-35/IL-37-Producing Plasma Cells in Chronic Periodontitis.

Authors:  L Jing; S Kim; L Sun; L Wang; E Mildner; K Divaris; Y Jiao; S Offenbacher
Journal:  J Dent Res       Date:  2019-05-03       Impact factor: 6.116

Review 6.  From proliferation to proliferation: monocyte lineage comes full circle.

Authors:  Filip K Swirski; Ingo Hilgendorf; Clinton S Robbins
Journal:  Semin Immunopathol       Date:  2014-01-17       Impact factor: 9.623

7.  Interleukin-3 amplifies acute inflammation and is a potential therapeutic target in sepsis.

Authors:  Georg F Weber; Benjamin G Chousterman; Shun He; Ashley M Fenn; Manfred Nairz; Atsushi Anzai; Thorsten Brenner; Florian Uhle; Yoshiko Iwamoto; Clinton S Robbins; Lorette Noiret; Sarah L Maier; Tina Zönnchen; Nuh N Rahbari; Sebastian Schölch; Anne Klotzsche-von Ameln; Triantafyllos Chavakis; Jürgen Weitz; Stefan Hofer; Markus A Weigand; Matthias Nahrendorf; Ralph Weissleder; Filip K Swirski
Journal:  Science       Date:  2015-03-13       Impact factor: 47.728

Review 8.  The immunopathology of sepsis and potential therapeutic targets.

Authors:  Tom van der Poll; Frank L van de Veerdonk; Brendon P Scicluna; Mihai G Netea
Journal:  Nat Rev Immunol       Date:  2017-04-24       Impact factor: 53.106

Review 9.  Re-thinking the functions of IgA(+) plasma cells.

Authors:  Jennifer L Gommerman; Olga L Rojas; Jörg H Fritz
Journal:  Gut Microbes       Date:  2014

10.  Engineered fusokine GIFT4 licenses the ability of B cells to trigger a tumoricidal T-cell response.

Authors:  Jiusheng Deng; Shala Yuan; Andrea Pennati; Jordan Murphy; Jian Hui Wu; David Lawson; Jacques Galipeau
Journal:  Cancer Res       Date:  2014-06-17       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.